Abatacept as Treatment for Diffuse Cutaneous Systemic Sclerosis Abatacept as Treatment for Diffuse Cutaneous Systemic Sclerosis

' Exploratory outcome measures during the open-label extension, including the composite ACR CRISS score, indicate that abatacept might promote overall global improvement in these participants. 'Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news